Page last updated: 2024-11-11

kaempferol 7-o-glucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

kaempferol 7-O-glucoside: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

kaempferol 7-O-beta-D-glucopyranoside : A kaempferol O-glucoside that is kaempferol attached to a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10095180
CHEMBL ID469441
CHEBI ID75790
SCHEMBL ID3462759
MeSH IDM0515479

Synonyms (38)

Synonym
kaempferol 7-o-glucoside
CHEMBL469441
chebi:75790 ,
kaempferol 7-o-beta-glucoside
16290-07-6
AKOS016004615
populnin
3,5-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl beta-d-glucopyranoside
kaempferol 7-o-beta-d-glucopyranoside
rzf1qn1z8r ,
kaempferol-7-o-beta-d-glucopyranoside
kaempferol-7-o-d-glucopyranoside
unii-rzf1qn1z8r
kaempferol 7-o-.beta.-d-glucopyranoside
kaempferol 7-o-glucoside (constituent of ginkgo) [dsc]
kaempferol-7-o-.beta.-d-glucopyranoside
SCHEMBL3462759
AC-34756
kaempferol-7-o-|a-d-glucopyranoside
kaempferol 7-glucoside
kaempferol 7-o-beta -d-glucopyranoside, >=90.0% (hplc)
bdbm226180
kaempferol 7-o-beta-d-glucoside (4)
mfcd08459623
3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Q3266683
kaempferol-7-glucoside; kaempferol-7-o-beta-d-glucopyranoside
3,5-dihydroxy-2-(4-hydroxyphenyl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
kaempferol-7-glucopyranoside
CS-0009619
HY-N0627
MS-28115
4h-1-benzopyran-4-one, 7-(beta-d-glucopyranosyloxy)-3,5-dihydroxy-2-(4-hydroxyphenyl)-
kaempferol 7-o-beta -d-glucopyranoside
XK171016
kaempferol-7-o--d-glucopyranoside
DTXSID301029781
kaempferol 7-o-glucoside (constituent of ginkgo)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
radical scavengerA role played by a substance that can react readily with, and thereby eliminate, radicals.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
kaempferol O-glucosideA glycosyloxyflavone that is an O-glucosylated derivative of kaempferol.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
trihydroxyflavoneAny hydroxyflavone carrying three hydroxy groups at unspecified positions.
flavonolsAny hydroxyflavone in which is the ring hydrogen at position 3 of the heterocyclic ring is replaced by a hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID717567Cytotoxicity against mouse BV2 cells assessed as cell viability at 20 uM by MTT assay relative to LPS-treated cells2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Flavonoid glycosides from the leaves of Allium victorialis var. platyphyllum and their anti-neuroinflammatory effects.
AID717568Antineuroinflammatory activity against mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess method2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Flavonoid glycosides from the leaves of Allium victorialis var. platyphyllum and their anti-neuroinflammatory effects.
AID1368908Cytotoxicity against human A2780 cells assessed as reduction in cell viability at 5 to 100 uM incubated for 24 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 01-15, Volume: 28, Issue:2
(-)-9'-O-(α-l-Rhamnopyranosyl)lyoniresinol from Lespedeza cuneata suppresses ovarian cancer cell proliferation through induction of apoptosis.
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID400524Antioxidant activity assessed as DPPH radical scavenging activity at 0.1 mg/mL2004Journal of natural products, Mar, Volume: 67, Issue:3
Antityrosinase principles and constituents of the petals of Crocus sativus.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]